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In vitro studies on space-
conforming self-assembling silk 
hydrogels as a mesenchymal stem 
cell-support matrix suitable for 
minimally invasive brain application
I. Osama ?, N. Gorenkova ?, C. M. McKittrick ?, T. Wongpinyochit ?, A. Goudie ?, F. P. Seib   ?ǡ ? & 
H. V. O. Carswell ?
Advanced cell therapies require robust delivery materials and silk is a promising contender with a long 
clinical track record. Our aim was to optimise self-assembling silk hydrogels as a mesenchymal stem cell 
(MSC)-support matrix that would allow future minimally invasive brain application. We used sonication 
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preliminary in vivo experiments to exhibit good space conformity in an ischemic cavity (intraluminal 
thread middle cerebral artery occlusion model) in adult male Sprague-Dawley rats (n = ?ȌǤ
informs on optimal MSC-hydrogel matrix conditions for minimally invasive application as a platform for 
future experiments targeting brain repair.
Cell-based therapy, especially the use of stem cells, is one of the main approaches that successfully promotes neu-
rorestoration of function and improves outcomes such as angiogenesis, neuroprotection, immune response and 
modulated inlammation in experimental models1. Stem cell therapy is now showing signs of success in human 
clinical trials2. For example, mesenchymal stem cells (MSCs) are appealing because these cells can be derived 
from an autologous cell source and they promote the repair of neurovascular units and exert potent immuno-
modulatory functions that result in neurorestorative efects in experimental models3. However, one key issue 
hindering the translation of cell therapies to the clinic is the lack of suitable cell delivery technologies that can 
support cell survival and provide transplanted cells with the necessary cues to perform their intended restorative 
functions such as trophic factor production3,4.
hese support and cueing functions are normally provided by the extracellular matrix (ECM), which is crit-
ical for the storage and presentation of growth and signalling factors and the provision of cell adhesion sites to 
guide and promote proliferation and survival. Physical cues, such as substrate elasticity and surface topography, 
also direct stem cell lineage commitment5,6. herefore, the ECM represents a critical signalling hub that allows 
(stem) cells to respond to their environment. he ECM can be mimicked quite efectively by engineered hydro-
gels7,8; however, clinical translation of stem cell therapies still requires the development of engineered materials 
to support function. Ideally, hydrogel materials should be biocompatible, biodegradable, minimally invasive, 
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programmable (i.e. solution-gel transition), cytocompatible and space conforming, and they should match brain 
tissue mechanics, show no material swelling and support even cell distribution (reviewed in9,10).
Many hydrogels presently being explored as carriers for cell therapies9,10 are derived from a broad spec-
trum of materials, including tissue-derived extracellular matrix, synthetic polymers, biopolymers, peptides and 
hybrid materials (reviewed in11,12). Examples include heparin13 or hyaluronic acid14 polyethylene glycol hybrid 
hydrogels, self-assembling RADA (ref.15) peptides functionalised with a laminin-derived IKVAV motif16, alg-
inate hydrogels15 and self-healing chitosan hydrogels17. Other materials include extracted extracellular matrix 
from Engelbreth-Holm-Swarm mouse sarcoma (i.e. Matrigel) or collagen from bovine or rodent tissues18. More 
recently, basement membrane and tunica propria ECM isolated from porcine urinary bladder is emerging as an 
interesting alternative to existing ECM preparations19,20.
All these systems have shown promise for brain repair, but these materials continue to show limitations. 
Emerging evidence suggests that ECM tissue speciicity is important for obtaining the desired treatment out-
come21, so ECM extracts from tumours or tissues that are unrelated to the brain are likely to require further 
optimisation. Single ECM component systems, such as collagen-based hydrogels, have been used extensively 
(reviewed in11), but these hydrogels have poor mechanical properties, limited resistance to biodegradation (or 
ability to ine tune this) and a marked tissue response22. Collagen is also predominantly of bovine origin, so its use 
in the nervous system raises theoretical risks of introducing prions directly into the brain. he development of 
biomimetic hydrogels (e.g. peptides, peptoids) and biohybrid hydrogel systems is promising, although these sys-
tems still require signiicant research eforts to yield self-assembling hydrogels with suiciently robust mechanical 
properties, in vivo biocompatibility and the desired performance12,23.
The silk from Bombyx mori has a long track record of use in humans24, as this biopolymer is clinically 
approved as a suture and surgical mesh25. Its renowned mechanical properties26, biocompatibility and biodegra-
dability27 make silk an ideal contender for applications that go beyond its current clinically approved load-bearing 
applications. he silk ibre can be completely reverse engineered into an aqueous silk solution28, which can then 
be processed into many diferent formats, including physically cross-linked hydrogels. It also has the ability to 
self-assemble in response to environmental triggers, making it particularly appealing for cell delivery applications 
(reviewed in29). Furthermore, silk is able to support cell growth and cell diferentiation of various stem cells, 
including pluripotent30, neural31,32 and MSC types33. Silk has therefore been investigated in a range of regenera-
tive medicine applications; however, at present, no studies have optimised self-assembling silk hydrogels-MSC 
conditions as a platform for future experiments on cell therapy into the brain.
Towards that, we hypothesized that B. mori silk could be used to generate a delivery system suitable for (i) 
minimally invasive application (for example, stereotactic injection for intracerebral delivery) and (ii) MSC 
support. For minimally invasive brain administration and stem cell support, the solution-gel characteristics 
and substrate elasticity are critical so we therefore focussed on optimising the physical and chemical cues of 
self-assembling silk hydrogels for brain administration and stem cell support. herefore the aim of the present 
study was to ine-tune the processing parameters of self-assembling silk hydrogels to generate a delivery system 
that shows controllable solution-gel kinetics, elasticity, space conformity and MSC-biocompatibility appropriate 
for administration to the brain.
Results
Physical assessment of self-assembling silk hydrogels. he solution-gel characteristics and elasticity 
of self-assembling silk hydrogels were assessed because control of these parameters is critical for minimally inva-
sive applications, including brain delivery. Silk self-assembly was initiated by sonication energy (Fig. 1a) and the 
visible kinetics of silk nanocrystal formation was monitored by light scattering (Fig. 1b). For all silk concentra-
tions, energy input increased light scattering even at the irst measurement point (i.e. within 10 minutes of energy 
input) when compared to the respective untreated silk solution controls. Over the subsequent 240 minutes, light 
scattering increased in a linear fashion; at 24 hours, the silk hydrogels showed the highest light scattering proper-
ties over the time frame tested. he extent of light scattering depended on the amount of silk present: the highest 
scattering values were observed for the 5% w/v hydrogels gels and lowest for 2% w/v hydrogels (note that 1% w/v 
silk did not form a robust hydrogel). Increasing the amount of silk also signiicantly changed the rheological prop-
erties, which were used to estimate silk hydrogel elasticity (Fig. 1c). he lowest substrate elasticity was observed 
for 2% w/v silk hydrogels and a near exponential increase was observed, from 0.17 to 5.46 kPa, for 2 and 5% w/v 
silk hydrogels, respectively. Visual inspection of the silk hydrogels (Fig. 1d) supported the observations made by 
light scattering and rheological measurements. First, an increasing level of opaqueness (i.e. light scattering) was 
evident for 1 to 5% w/v silk samples (note that the liquid 1% w/v silk sample was also opaque). Second, the overall 
mechanical strength increased for the 2 to 5% w/v silk hydrogels, while 1% silk remained liquid.
Structural assessment of self-assembling silk hydrogels. Scanning electron microscope of silk 
hydrogels showed a porous silk structure for 2% w/v silk hydrogels and progressively less porosity for the high 
concentration samples (Fig. 2a). Secondary structure analysis by FTIR analysis showed an amide I absorp-
tion peak at 1625 cm−1 (i.e. β-sheet) for all silk hydrogels (Fig. 2b). FTIR measurements were complemented 
by dynamic CD measurements of silk hydrogels. Ellipticity at 217 nm was used to track β-sheet conformation 
between 1 and 24 hours post sonication. At a lower silk content, the hydrogel showed a time-dependent increase 
in β-sheet content over 24 hours, whereas hydrogels with a higher silk content had essentially completed β-sheet 
formation by 1 hour post sonication.
Space conformity and absence of swelling for self-assembling silk hydrogels. Space conforming 
properties without swelling are important properties as the materials designed to ill a cavity should not compress 
the surrounding tissue in order to be minimally invasive. he in vitro swelling studies showed that the weights of 
www.nature.com/scientificreports/
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the self-assembling silk hydrogels did not difer during the solution-gel transition or following overnight incuba-
tion in PBS (Fig. 3a).
he conformity of the self-assembling silk hydrogels was then assessed in vitro before and ater the comple-
tion of the solution-gel transition. Visual inspection showed that only silk samples that were still in the solution 
state achieved complete space illing (Fig. 3b, let cuvette). A quantitative measurement of space conformity was 
devised by determining the amount of silk that was able to ill a pre-deined space. For 3% w/v and 4% w/v silk 
samples, signiicantly more silk could be applied to a ixed volume when silk was in the solution state rather than 
in the gelled state; however, no statistical diference was observed for 2% w/v silk samples (Fig. 3c).
Preliminary in vivo experiments, were designed to provide qualitative proof of concept insight to support these 
in vitro results on space conformity. One excellent model system is experimental stroke which provides a cavity 
for space conformity to be visualised. Ater chronic cerebral ischemia, application of the self-assembling silk 
hydrogels to the afected hemisphere resulted in excellent conformal it (Supplementary Fig. S1). However, injec-
tion of self-assembling silk hydrogels in mice with no apparent infarct cavity (i.e. the lesion had not fully devel-
oped) resulted in silk hydrogel accumulation in the ventricle with excellent space conformity (Supplementary 
Fig. S1). In rats with small and medium lesions (i.e. cavities of variable sizes, detailed in Supplementary Fig. S3), 
injection of self-assembling silk hydrogels into the afected area showed excellent space conformity, a seamless 
tissue-silk hydrogel interface, and no gross adverse tissue response 7 days ater application (Fig. 4). he silk 
hydrogel appeared intact, with no obvious signs of degradation.
Cytocompatibility, injectability and distribution of MSCs in self-assembling silk hydro-
gels. Exploiting self-assembling silk hydrogels for cell delivery requires that these systems be cytocompatible, 
injectable and tuneable to control cell distribution within the three dimensional hydrogel structure. An initial 
drop in MSC viability was observed for all hydrogels (Fig. 5a). For 2% w/v silk hydrogels, the cell viability was 
stabilised at day 2 and signiicant cell proliferation was observed from day 5 onwards, over the next 10 days, until 
the end of the study period. Of all the hydrogels studied, the 2% w/v hydrogels supported the best MSC growth 
(Fig. 5a). For 3% w/v and 4% w/v hydrogels, the cell viability stabilised at day 3 and then steadily increased over 
the remaining culture period (up to 14 days) (Fig. 5a).
he impact of injection shearing on cell viability was also assessed using silk still in the solution state and in 
the gelled state (Fig. 5b). For 2% w/v silk, the use of only the smallest gauge needle (30G) resulted in a substantial 
drop in cell viability when the gelled samples, rather than the liquid samples, were injected. his diference was 
less noticeable for 25G needles and was not observed for 21G needles. For 3% w/v silk samples, no diference was 
noted between the samples when a 21G needle was used. However, a signiicant and size-dependent reduction 
Figure 1. Self-assembling silk hydrogel manufacture and structural characteristics. he resulting hydrogels show 
controllable solution-gel kinetics and mechanical properties. (a) Schematic illustration of the manufacture of silk 
hydrogels from reverse engineered silk. (b) Light scattering to assess the formation of silk nanocrystallites over 
time. (c) Matrix elasticity of silk hydrogels measured by rheology (dotted line indicates typical stifness reported 
for brain tissue while shading indicates the reported spectrum). (Mean ± SD, n ≥ 3 independent experiments; n.s. 
(non-signiicant) or ***P < 0.001 versus 2% w/v self-assembling silk hydrogel). (d) Representative macroscopic 
images of self-assembling silk hydrogels with increasing concentrations (scale bar 10 mm).
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in cell viability was noted between gelled and solution samples ater injection though 25G and 30G needles. he 
4% w/v silk samples gave similar results, but a signiicant reduction in cell viability was even observed with a 21G 
needle (Fig. 5b). Following injection (i.e. needle shearing forces), cell viability was better preserved for all solution 
silk samples than for the respective hydrogels.
Using an injectable biomaterial for cell delivery requires control over the (even) distribution of viable cells 
throughout the carrier matrix. herefore, MSC distribution in the silk hydrogels was assessed by histology 
(Fig. 6a). MSCs were added to sonicated silk within 10 and 60 minutes of the solution-gel transition: at 10 min-
utes, an even distribution of cells was observed at every level throughout the hydrogel, whereas at 60 minutes, 
most cells had sunk to the bottom of the hydrogel due to gravity (Fig. 6b). Preliminary experiments in ischemic 
Figure 2. Morphology and secondary structure of self-assembling silk hydrogels. (a) Representative scanning 
electron micrographs of silk hydrogels. (b) FTIR spectra of silk hydrogels with absorption bands for random 
coils (solid line) and β-sheets (dashed line, 1625 cm−1) (n = 2 independent experiments). (c) Circular dichroism 
measurements of a silk solution undergoing solution-gel transition following sonication energy input (note 
Ellipticity at 217 nm represent β-sheets) (one independent experiment).
Figure 3. Space conformity and swelling of self-assembling silk hydrogels. (a) Assessment of swelling of self-
assembling silk hydrogels. Weight recordings of silk undergoing the solution-gel transition; the respective 
hydrogel weights before, during and ater incubation with phosphate bufered saline. (b) Qualitative images of 
3% w/v silk samples added to a cuvette in the pre- and post-gelled state using a sample volume of 1 ml (scale bar 
10 mm). (c) Quantitative assessment of space conformity of silk hydrogels. (Mean ± SD, error bars hidden in 
bars when not visible, n = 3 to 6 independent experiments; ***P < 0.001).
www.nature.com/scientificreports/
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mice showed that addition of cells to silk undergoing the solution-gel transition within the 10 minute time win-
dow resulted in uniform cell distribution in vivo (Supplementary Fig. S2).
Discussion
To date, no hydrogel system has been introduced into clinical practice for the delivery of cells to the brain, 
despite the position of several biopolymers at the clinical forefront. For example, multivalent cation-induced 
self-assembly of alginate has been exploited for encapsulation of genetically modified MSCs to express 
glucagon-like peptide-1 (i.e. GLP-1 CellBeads)34. hese GLP-1 CellBeads have progressed to Phase I clinical trials 
(ClinicalTrials.Gov identiier: NCT01298830) for treatment of ischemic stroke. However, the lack of long-term 
mechanical robustness and challenges in navigating regulatory hurdles remain signiicant weaknesses of this 
delivery system. In addition, it ultimately requires surgical removal. Silk, by contrast, has a robust clinical track 
record in humans24 and our ability to reverse engineer silk is introducing new silk formats for novel applications29.
Cell delivery to the brain is emerging as a promising therapeutic strategy. However, current delivery technolo-
gies (e.g. simple injection of cells without a matrix) fall short of our insight into (stem) cell niches thus potentially 
undermining their therapeutic potential by stripping them of their supportive microenvironment (reviewed in9,10). 
We therefore explored the suitability of self-assembling silk hydrogels for future minimally invasive cell appli-
cation; one potential scenario is the administration to the brain and for supporting stem cells. For minimally 
invasive brain administration, the solution-gel characteristics and substrate elasticity are critical so we therefore 
Figure 4. Space conformity of self-assembling silk hydrogels in lesions of variable sizes. (a) Experimental 
timeline for the stroke model in rats, injection of 4% w/v self-assembling silk hydrogel and assessment. 
Representative images of coronal H&E stained sections at the level of (b) the Bregma 1.2 mm; small-sized 
lesion (dotted outline), 1: cortex; 2: boarder between cortex and striatum; 3: silk grat. Boxed area and zoom 
show hydrogel inside the small lesion; and (c) at the level of the Bregma −0.26 mm; medium-sized lesion 
(dotted outline), 1: cortex; 2: boarder between cortex and striatum; 3: processing artefact resulting in splitting 
of section. Boxed area and zoom show the hydrogel area illing the cavity and surrounded by cells (arrows). See 
Supplementary Fig. S3 for the respective lesion topography.
www.nature.com/scientificreports/
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focussed on optimising the physical and chemical cues of self-assembling silk hydrogels for brain administration 
and stem cell support. Energy input into a silk solution displaces solvating water molecules and exposes the 
hydrophobic silk domains, which subsequently rearrange and grow into nanocrystallites33. Secondary structure 
analysis by FTIR and CD (Fig. 2b and c, respectively) showed that these nanocrystallites were β-sheets and thus 
represented the points of physical crosslinking within the hydrogel. hese nanocrystallites are responsible for the 
observed light scattering and gave rise to the observed opaqueness of the silk hydrogels (this contrasts with chem-
ically cross-linked silk hydrogels, which are transparent to visible light)29. As expected, the overall solution-gel 
kinetics were concentration dependent, with higher silk concentrations forming mechanically stable hydrogels 
more rapidly. he lower threshold for the formation of silk hydrogels was 1% w/v (Fig. 1d); in all probability, this 
concentration did not contain suicient silk to form a mechanically robust hydrogel network, despite the forma-
tion of nanocrystallites. Overall, the observed changes in secondary structure and the solution-gel transition were 
in good agreement with those reported in previous studies33,35.
Control over mechanical properties, such as stifness, is also essential to recreate an orphan tissue microen-
vironment that can support (stem) cell function, tissue growth and seamless integration with existing tissues7. 
Increasing silk content resulted in increased stifness in the respective silk hydrogels due to the presence of nano-
crystallites that provided mechanical strength (Fig. 1c). At 2 to 4% w/v, the silk hydrogels exhibited matrix elas-
ticity similar to that of brain tissue (0.1 to 1 kPa, indicated by dotted line and shading, Fig. 1c)36. Qualitative 
assessment of these hydrogels by scanning electron microscopy showed a porous three-dimensional structure.
For the clinical translation of (self-assembling) hydrogels for intracerebral injection, good space-conforming 
properties without swelling are necessary to avoid compression against adjacent tissues, as this can further exacer-
bate cellular injury and clinical symptoms9,10. he self-assembling silk hydrogels exhibited no swelling during the 
solution-gel transition and showed excellent space conformity in vitro when injected in the pre-gelled state, espe-
cially at a higher silk content (Fig. 3a,b and c). In support of our in vitro results, preliminary in vivo experiments 
allowed visualisation of good space conformity in an ischemic cavity, in mice (Supplementary Fig. S1) and rats 
(Fig. 4) using 3% w/v and 4% w/v self-assembling silk hydrogels, respectively with no apparent adverse efects on 
animal health or behaviour (Supplementary Fig. S1). his observation agreed with the work by Fernández-García 
and co-workers, who showed that the use of silk hydrogels in healthy mice caused no considerable cognitive or 
sensorimotor deicits in either behavioural tests or electrophysiological analyses37 and, though outwith the scope 
of the present study, provide a platform for future experiments that characterise cellular phenotype and survival 
as well as compatibility in the brain tissue ater transplantation. he ability to ill irregularly shaped defects by 
injecting a self-assembling material without the need for premoulding is essential for many therapeutic applica-
tions, including the stroke setting.
One therapeutic strategy is the use of MSCs (reviewed in1,2,38). herefore, we examined the performance of 
MSCs following their embedding within self-assembling silk hydrogels in vitro. Over the course of the study 
period, the MSCs proliferated, although they showed a transient decrease in cell viability for the irst 3 days 
(Fig. 5a). Similar observations have been made previously with (silk) hydrogel systems (e.g33,39,40.). For example, 
Wang and co-workers showed MSC proliferation over 21 days in 4% w/v silk hydrogels but negligible prolifera-
tion (and a degree of cell death) in 8% w/v and 12% w/v hydrogels. his efect of high silk concentrations likely 
relects nutrient mass transport limitations and possible mechanical restrictions imposed by the hydrogels33.
Figure 5. Cytocompatibility of MSCs in self-assembling silk hydrogels. (a) Viability of MSCs encapsulated in 
self-assembling silk hydrogels for up to 14 days. (b) Viability of MSCs encapsulated in pre-gelled or post-gelled 
silk hydrogels and injected through 21, 25 and 30 gauge needles. (mean ± SD, n ≥ 3 independent experiments; 
*P < 0.05, **P < 0.01, ***P < 0.001).
www.nature.com/scientificreports/
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We speculate that, over time, MSCs are able to modify the silk hydrogel by endogenous ECM deposition. 
he diferential response of MSCs to 2 and 4% w/v silk hydrogels reported here suggests a direct inluence of 
mechanobiology on MSC cell proliferation, which is not a unique efect of silk. For example, MSCs in collagen 
mimetic peptide hydrogels had better cell viability on soter hydrogels40; similar observations have also been 
made with diferent stem/progenitor cells and hydrogel systems (e.g. neural stem/progenitor cells and meth-
acrylamide chitosan)39. MSC cultures growing on two-dimensional silk hydrogels showed a more spindle shaped 
morphology on sot silk hydrogels (6 kPa) and progressively spread out on stifer substrates41. Treatment of MSCs 
Figure 6. Impact of the solution-gel transition on cell distribution in self-assembling silk hydrogels in vitro. 
Cells were added at 10 minutes or 60 minutes before the completion of the solution-gel transition. (a) Histology 
images of MSCs encapsulated in silk hydrogels stained in vitro with H&E. Images were segmented into 4 
regions (see Supplementary Fig. S4 for clarity of our methodological approach) and (b) the cell distribution was 
quantiied. Note that for the 60 minute samples most of the cells had descended by gravity to the bottom of the 
hydrogel (level 4) (b, mean ± SD, n = 3 independent experiments; *P < 0.05, **P < 0.01).
www.nature.com/scientificreports/
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with transforming growth factor 1 enabled the transition to a vascular smooth muscle cell phenotype and the best 
results were achieved using silk hydrogels of medium stifness (33 kPa)41. Overall, (silk) mechanics is emerging as 
an important factor in MSC biological responses.
Application of a therapeutic payload to the brain is an appealing therapeutic avenue, but it requires minimally 
invasive administration of the payload. Delivery of MSCs requires a sustained cell viability and eicient cell distri-
bution. We found that MSCs encapsulated in silk hydrogel that gelled within 10 minutes showed excellent cell dis-
tribution throughout the hydrogel, when compared to longer solution-gel transition times where gravity resulted 
in MSC settling (Fig. 6). Shear stress also afected MSC viability (Fig. 5b); as expected, cell viability was higher 
following injection from 21G needles than from narrower bore 25G and 30G needles, and the best results were 
achieved with pre-gelled systems. In human clinical trials, delivery of stem cells into the cavity typically requires 
a custom-made needle with an internal diameter of 0.35 mm (similar to 22G to 23G) (e.g.42). We therefore used 
gauge size 22G and 26G needles in our rat and mouse pre-clinical stroke models, respectively. hese needle sizes 
limit tissue damage but are also relevant for cell delivery. Preliminary studies in mouse stroke model showed 
uniform cell distribution (Supplementary Fig. S2).
Conclusions
Taken together, this study provides valuable information regarding the optimal MSC-hydrogel matrix combi-
nations for future experimental studies targeting central nervous system repair. he key indings of the present 
study are that (i) self-assembling silk hydrogels exhibit controllable solution-gel kinetics, elasticity, and secondary 
structure, (ii) these self-assembling silk hydrogels can be ine-tuned to achieve uniform cell distribution, viability 
and space conformity in the absence of any silk hydrogel swelling; and (iii) preliminary proof-of-concept studies 
allowed visualisation of space conformity of self-assembling silk hydrogels ater injection into the brain. Overall, 
our in vitro data indicates that 3% w/v silk hydrogels, which gelled within 10 min of MSC addition, should be 
injected in the pre-gelled state to provide optimal support of MSC viability and distribution.
Materials and Methods
Silk solution preparation. Bombyx mori silk cocoons were reverse engineered as detailed previously28; for 
a video-based protocol, see43. Briely, dried cocoons (Tajima Shoji Co., Yokohama, Japan) were degummed for 
60 minutes in 25 mM Na2CO3 and then rinsed in ddH2O to remove sericin. Dried degummed silk ibres were 
dissolved in 9.3 M LiBr solution at 60 °C for 3 to 4 hours. he resulting solution was dialysed against ddH2O using 
a dialysis cassette (molecular cut of of 3,500 Da; hermo Fisher Scientiic Inc., Waltham, MA, USA) for 2 days, 
with several changes of water, to remove LiBr salts. he resulting aqueous silk solution (typically between 6 to 
7% w/v) was centrifuged to remove any silk aggregates and the resulting silk solution was stored at 4 °C until use.
Manufacture, monitoring and characterisation of self-assembling silk hydrogels. Self-assembling 
silk hydrogels were prepared using a digitally controlled probe sonicator (Sonoplus HD 2070, Bandelin, Berlin, 
Germany) itted with a 23 cm long sonication tip (0.3 cm diameter tip and tapered over 8 cm). Unless otherwise 
stated, 4 to 8 ml sample batches in 15 ml Falcon tubes (1.4 cm diameter and 11 cm long) (Greiner Bio-One GmbH, 
Kremsmünster, Austria) were exposed to a 30% amplitude for typically 3 to 6 sonication cycles on ice (one cycle 
consisted of 30 seconds on and 30 seconds of) to induce the solution-gel transition of 1 to 5% w/v silk samples 
(Fig. 1a). One method used to track the solution-gel transition was to measure light scattering at 405 nm (Spectra 
Max M5, Molecular devices, Sunnyvale, CA, USA), because physically crosslinked silk hydrogels develop nano-
crystalline regions that scatter light29. In the present study, this was done by subjecting the silk solution samples 
to two 30 second sonication cycles, and light scattering was monitored for 24 hours.
Circular dichroism (CD) spectroscopy was used to assess the kinetic transition from a random coil to a stable 
β-sheet. Following sonication, samples were immediately loaded into a 0.01 mm path length measuring cell. he 
temperature was kept constant at 25 °C, and the samples were scanned at one single time with a CD spectrometer 
(Chirascan-plus, Applied Photophysics Ltd, Leatherhead, UK) over the 190 to 250 nm spectrum with a 1 nm res-
olution and 3 scans per time point over 24 hours. he change in ellipticity at 217 nm was used to monitor β-sheet 
formation. he silk secondary structure was assessed using Fourier transform infrared (FTIR) spectroscopy, with 
measurements being repeated (total twice). For FTIR measurements, the silk hydrogel samples were exposed to 
128 scans at 4 cm−1 resolutions over the wavenumber range 400 to 4000 cm−1 using a TENSOR II FTIR spectrom-
eter (Bruker Optik GmbH, Ettlingen, Germany). Baseline and peak it were corrected by OriginPro 9.2 sotware 
at the amide I region (1595–1705) as detailed previously44. he amide I region was identiied and deconvoluted, 
as follows: 1605−1615 cm−1 as side chain/aggregated strands, 1616−1637 cm−1 and 1697−1703 cm−1 as β-sheet 
structure, 1638−1655 cm−1 as random coil structure, 1656−1662 cm−1 as α-helical bands and 1663−1696 cm−1 
as β-turns.
For rheological assessments, 2 to 5% w/v silk hydrogels (0.2 ml) were prepared and equilibrated in PBS over-
night. he hydrogels were then subjected to rheological characterization (Kinexus pro+ rheometer, Malvern 
Instruments Ltd., UK) using a 20 mm diameter plate set to 25 °C and appropriate gap size. Strain stress was meas-
ured irst from 0.1 to 100% with at a set frequency of 1.0 Hz, followed by a frequency sweep.
For scanning electron microscopy (SEM), silk hydrogels were frozen and then freeze dried (Micro Modulyo, 
hermo Fisher Scientiic Inc.). Dried samples were immediately moved to a desiccator and sputter coated with 
carbon using a vacuum coater (Polaron Division E6100, Bio-Rad, Birmingham, UK). Coated samples were 
imaged twice with a FE-SEM SU6600 scanning electron microscope (Hitachi High Technologies, Krefeld, 
Germany) using 5 kV acceleration voltage. Electron micrographs were analysed using ImageJ v1.50i (National 
Institutes of Health, Bethesda, MD, USA).
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Assessment of silk hydrogel swelling and space conformity. To determine silk hydrogel swelling, 
300 µl of sonicated silk solution was added to pre-weighed Eppendorf tubes and weighed. Once the hydrogel had 
gelled, phosphate bufered saline (PBS; 300 µl) was added carefully on top of the silk hydrogel, the tubes were 
re-weighed and let for 24 hours. Ater complete removal of PBS, the inal weight was determined. he swelling 
ratio was calculated using the initial silk solution weight and the inal weight ater 24 hours of PBS incubation. 
he silk hydrogels were generated (detailed above) and subjected to in vitro space conformity testing. Sonicated 
silk samples were drawn up into 1 ml syringes (without a needle), and either (i) the silk sample was let in the 
syringe to complete the solution-gel transition and subsequently transferred to a cuvette, or (ii) the silk sample 
was immediately transferred from the syringe to the cuvette (i.e. still in its liquid form) and allowed to gel in 
the cuvette. In both conditions, the cuvettes were illed with the silk hydrogel samples up to the 1 ml mark. he 
cuvettes were then weighed and the conformity was calculated using the theoretical weight of the respective 1 ml 
sample as 100%.
Preparation and assessment of mesenchymal stem cells in self-assembling silk hydrogels. Mouse 
C3H10T0.5 mesenchymal stem cells (American Type Culture Collection) were grown on tissue culture treated pol-
ystyrene lasks (Corning Inc., New York, USA) and cultured in Roswell Park Memorial Institute medium 1640 con-
taining 4.5G GlutaMAX, supplemented with 10% v/v foetal bovine serum and penicillin and streptomycin (50 U/mL 
penicillin and 50 µg/mL streptomycin) (hermo Fisher Scientiic). Cells were maintained in a humidiied atmosphere 
of 5% CO2 at 37 °C, and subconluent cultures were routinely subcultured with trypsin/EDTA every 2 to 3 days.
For silk hydrogel cell culture studies, the silk solution was ilter sterilised (33 mm Millex-GP syringe ilter 
itted with a polyethersulfone membrane with 0.22 µm pores) and the silk solution was sonicated on ice in a class 
II biological safety cabinet. Next, 10× PBS was added to the aqueous silk solutions to yield an isotonic solution 
and C3H10T0.5 cells (2 × 105 cells per 50 µl of silk were added to the processed silk samples at 28 °C to 32 °C). he 
exact timing of cell addition was established by monitoring the low characteristics of the silk sample. Uniform 
cell seeding throughout the silk hydrogel was achieved by adding cells once the initiation of the solution-gel tran-
sition was evident. he MSC silk mixture (2 × 105 cells in 50 µl) was pipetted into a 96-well plate well (well surface 
area 0.32 cm2) and transferred to the cell incubator for 10 to 30 minutes to allow completion of the solution-gel 
transition. Next, 200 µl of complete culture medium was carefully added on the top of the mixture, and this was 
changed every 3 days. Cell viability was assessed by adding 25 µl AlamarBlue (hermo Fisher Scientiic) to the 
respective well and the cells were allowed to metabolise the substrate for 4 hours. he culture supernatant was 
then transferred to a black 96-well plate (Sigma-Aldrich, St. Louis, MO, USA) and measured with a luorescence 
plate reader (POLARstar Omega BMG LABTECH GmbH, Ortenburg, Germany) by ixing the photo multiplier 
tube and setting the excitation and emission ilters to 560 nm and 590 nm, respectively.
he viability of the MSCs in silk hydrogels post-injection was assessed by injecting 50 µl of silk MSC sample 
mixtures in either the pre-gelled (i.e. in the liquid form) or post-gelled state through diferent needle gauges (21, 
25 and 30G) into 96-well plates to establish the efect of shear stress on cell viability. he cell viability was assessed 
within 180 minutes ater injection using AlamarBlue, as detailed above. his short time frame was selected to 
assess shear stress induced changes in viability while minimizing diferences due to proliferation.
In a inal set of in vitro studies, the distribution of encapsulated MSCs in silk hydrogels was assessed by histol-
ogy. he solution-gel transition was ine tuned to occur within 10 or 60 minutes. During this solution-gel tran-
sition time window, cells were added to the silk samples and the MSC silk mixture was transferred into 24-well 
plate Transwell inserts with the smallest pore size of 0.4 µm to mitigate sample leakage (Corning Life Sciences 
B.V., Amsterdam, he Netherlands). hese Transwell inserts have a surface area of 0.32 cm2 and therefore resem-
ble the 96-well plate format used in our study. To facilitate sample handling, the MSC silk mixture was scaled up 
to 200 µl. Once the silk samples had completed their solution-gel transition, the Transwell membrane was cut to 
facilitate removal of the intact silk hydrogels. he hydrogels were ixed in 4% paraformaldehyde for 30 minutes, 
then immersed in sucrose (30% w/v) overnight at 4 °C, frozen in isopentane/dry ice at −42 °C for 2 minutes and 
cryosectioned. he 20 µm sections were stained using haematoxylin and eosin. A minimum of 3 consecutive 
sections per sample were analysed. Each image was segmented into 4 equal levels, based on their depth in the 
hydrogel in the Transwell, with level 4 being at the bottom of the hydrogel in the Transwell and level 1 being at 
the top of the hydrogel in the Transwell (see Supplementary Fig. S4). Levels 1–4 are shown on the Fig. 6a on the 
let hand sides of the images. he number of cells in each level was counted. he purpose of the 4 levels was to 
quantify whether the cells had sunk to the bottom of the hydrogel in the Transwell or whether the cells had equal 
distribution throughout the hydrogel.
Rat stroke model and administration of self-assembling silk hydrogels. Preliminary experiments 
were designed to allow visualisation of space conformity in vivo. All in vivo studies were approved by the Home 
Oice of the United Kingdom (Project License Number 60/4469). All procedures complied with the UK Animals 
(Scientiic) Procedures Act (1986) and the Ethical Review Process of the Institute of Pharmacy and Biomedical 
Sciences at the University of Strathclyde. he in vivo studies followed the ARRIVE guidelines45. Animals were 
kept under a 12 hour light/dark cycle and were fed ad libitum. he in vivo studies were conducted in rodent 
models. he rat data are shown in the manuscript. he mice data are shown in Supplementary information only.
he rat study was performed as detailed previously46. Briely, male Sprague-Dawley rats (n = 4, weight 240–
290G, 8–9 weeks, Harlan, UK) underwent a right transient middle cerebral artery occlusion for 60 minutes by 
insertion of a propylene ilament (Doccol Corporation; tip diameter with coating 0.33 +/− 0.02 mm), via the 
common carotid artery to the ostium of the middle cerebral artery in the circle of Willis. A priori exclusion cri-
terion was any animal found to be moribund due to excessive weight loss (>20% of start weight). No animals 
were excluded based on this exclusion criteria, however one animal was excluded due to damage to tissue during 
processing of the tissue for histology, leading to a inal n number n = 3. At 14 days ater this middle cerebral artery 
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occlusion, 10 µl of 4% w/v self-assembling silk hydrogel was injected at a rate of 2 µl/minute at coordinates (L) 
−1.5 mm, (A-P) −3.5 mm and (V) −6.5 mm, using a Hamilton syringe with a 22 gauge blunt tip needle. Animals 
were terminally anaesthetised at 1 week ater the transplantation by overdosing with sodium pentobarbital. A tran-
scardial perfusion of 0.9% w/v saline was followed by 4% w/v ice-cold paraformaldehyde in 0.2 M PBS. Brains were 
removed following craniotomy and were ixed in paraformaldehyde for 24 hours. he brains were then immersed 
in cryoprotective solution (30% w/v sucrose in PBS with 0.01% w/v sodium azide for 72 hours, followed by rapid 
freezing on dry ice). Coronal (40 µm) cryostat sections were cut and stained with haematoxylin and eosin.
Statistical analyses. Data were analysed using GraphPad Prism 7.0 (GraphPad Sotware, La Jolla, CA, 
U.S.A.). Sample pairs were analysed with the Student’s t-test. Multiple samples were evaluated by one-way anal-
ysis of variance (ANOVA), followed by Dunnett’s multiple comparison post hoc test. Asterisks were used to 
denote statistical signiicance as follows: *P < 0.05, **P < 0.01, ***P < 0.001. All data were presented as mean 
values ± standard deviation (SD). he number of independent experiments (n) is noted in each igure legend.
Data Availability Section
All data created during this research are openly available from the University of Strathclyde-Pure, at https://doi.
org/10.15129/2bbce19a-4b47-43d9-b9d5-7549b4d9ae4a.
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